微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 3.97% | 45.96% | -11.38% | 15/70 | 2.21% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | 4.48% | -27.39% | -3.24% | 37/70 | 3.08% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | 4.63% | -26.16% | 26.5% | 36/70 | 3% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | 3.66% | -1.08% | 34.56% | 33/70 | 0.63% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 2.72% | 40.93% | -55.92% | 28/70 | 1.5% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 6.17% | 136.75% | -1.59% | 38/70 | -0.11% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 6.27% | 361.25% | 69.46% | 41/70 | 7.09% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 3.7% | 1661.91% | 91.71% | 44/70 | 4.8% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 1.93% | 421.62% | 111.49% | 46/70 | 3.14% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | -16.79% | -8.96% | -599.58% | 65/70 | 6.41% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | -2.4% | 48.94% | -1242.86% | 63/70 | 5.07% | 片仔癀 | 23.54% | 行业排名> |
| 2022-06-30 | 0.21% | 107.72% | -43.24% | 60/70 | 3.13% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | 0.37% | 76.19% | 102.4% | 58/70 | 2.15% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | -15.41% | -4180.56% | -227.87% | 64/70 | 4.45% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | -4.7% | -273.43% | -72.79% | 65/70 | 7.44% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | -2.72% | -340.71% | -1395.24% | 66/70 | 4.61% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 0.21% | -81.9% | 158.33% | 63/70 | 2.67% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | -0.36% | -107.48% | -113.28% | 62/70 | 0.09% | *ST长药 | 7.37% | 行业排名> |
| 2020-09-30 | 2.71% | -63.38% | 139.82% | 56/70 | 6.69% | 沃华医药 | 22.84% | 行业排名> |
| 2020-06-30 | 1.13% | -73.47% | -2.59% | 56/70 | 3.67% | 沃华医药 | 19.47% | 行业排名> |
| 2020-03-31 | 1.16% | -53.04% | -75.88% | 48/70 | 2.09% | 沃华医药 | 12.7% | 行业排名> |
| 2019-12-31 | 4.81% | -73.16% | -35% | 44/70 | 5.69% | 济川药业 | 7.33% | 行业排名> |
| 2019-09-30 | 7.4% | -33.63% | 73.71% | 34/70 | 7.19% | 济川药业 | 27.43% | 行业排名> |
| 2019-06-30 | 4.26% | -40.08% | 72.47% | 38/70 | 4.65% | 济川药业 | 23.05% | 行业排名> |
| 2019-03-31 | 2.47% | -7.14% | -86.22% | 37/70 | 2.89% | 济川药业 | 15.79% | 行业排名> |
| 2018-12-31 | 17.92% | 57.75% | 60.72% | 9/70 | 7.76% | 华润三九 | 10.23% | 行业排名> |
| 2018-09-30 | 11.15% | 89.3% | 56.82% | 13/70 | 7.93% | 济川药业 | 32.79% | 行业排名> |
| 2018-06-30 | 7.11% | 70.91% | 167.29% | 20/70 | 4.95% | 济川药业 | 27.55% | 行业排名> |
| 2018-03-31 | 2.66% | 88.65% | -76.58% | 32/70 | 2.72% | 济川药业 | 17.62% | 行业排名> |
| 2017-12-31 | 11.36% | -19.49% | 92.87% | 27/70 | 9.83% | 济川药业 | 10.07% | 行业排名> |
| 2017-09-30 | 5.89% | -3.6% | 41.59% | 45/70 | 8.33% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-06-30 | 4.16% | 36.84% | 195.04% | 43/70 | 5.2% | 济川药业 | 24.2% | 行业排名> |
| 2017-03-31 | 1.41% | 27.03% | -90.01% | 46/70 | 2.61% | *ST大药 | 15.31% | 行业排名> |
| 2016-12-31 | 14.11% | 1028.29% | 130.93% | 19/70 | 10% | 济川药业 | 14.64% | 行业排名> |
| 2016-09-30 | 6.11% | 1098.04% | 100.99% | 38/70 | 9.36% | 济川药业 | 7.64% | 行业排名> |
| 2016-06-30 | 3.04% | 132% | 173.87% | 48/70 | 5.05% | 维康药业 | 38.23% | 行业排名> |
| 2016-03-31 | 1.11% | 179.29% | 173.03% | 45/70 | 4.07% | 太极集团 | 58.41% | 行业排名> |
| 2015-12-31 | -1.52% | 95.88% | -398.04% | 62/70 | 11.33% | 新光药业 | 16.54% | 行业排名> |
| 2015-09-30 | 0.51% | -86.82% | 105.37% | 51/70 | 8.45% | 太极集团 | 71.6% | 行业排名> |
| 2015-06-30 | -9.5% | -310.64% | -578.57% | 56/70 | 5.5% | 维康药业 | 48.67% | 行业排名> |
| 2015-03-31 | -1.4% | 92.78% | 96.21% | 54/70 | 2.94% | 济川药业 | 21.37% | 行业排名> |